Redwood City, California, United States In 2001 was created SB Life Science, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Redwood City.
The top activity for fund was in 2005. The higher amount of exits for fund were in 2013. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this SB Life Science performs on 14 percentage points more the average number of lead investments.
The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the SB Life Science, startups are often financed by Unilever Ventures, Maverick Ventures, CSK Venture Capital. The meaningful sponsors for the fund in investment in the same round are Unilever Ventures, Maverick Ventures, Zesiger Capital. In the next rounds fund is usually obtained by Zesiger Capital, Unilever Ventures, Sano Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Health Care. Among the various public portfolio startups of the fund, we may underline Perlegen Sciences, Kadmus Pharmaceuticals, Optimer Pharmaceuticals
Related Funds
Funds with similar focus
| Fund Name | Location |
| GREAT WALL GLORY SECURITIES | China, Fujian, Xiamen |
| Next Fifteen Communications Group | England, London, United Kingdom |
| Regis and Savoy Capital Privy | Bangalore, India, Karnataka |
| Rentracks | Edogawa, Japan |
| Shin-Kong Capital | - |
| Skip Capital | Australia, New South Wales, Sydney |
| Sustainable Titania Technology | Japan, Tokyo |
| Tectonic Capital | New York, New York, United States |
| WiLAN | Canada, Ontario, Ottawa |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Gemin X Pharmaceuticals | $38M | 03 Jul 2008 | Montreal, Quebec, Canada | ||
CircuLite | $5M | 23 Apr 2007 | Framingham, Massachusetts, United States | ||
Kadmus Pharmaceuticals | $15M | 10 Feb 2004 | California, United States | ||
Perlegen Sciences | $30M | 28 Jan 2003 | Mountain View, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Gemin X Pharmaceuticals | $38M | 03 Jul 2008 | Montreal, Quebec, Canada | ||
CircuLite | $5M | 23 Apr 2007 | Framingham, Massachusetts, United States | ||
Kadmus Pharmaceuticals | $15M | 10 Feb 2004 | California, United States | ||
Perlegen Sciences | $30M | 28 Jan 2003 | Mountain View, California, United States |
